Neurociencia del consumo y dependencia de sustancias psicoactivas

NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVAS
Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular
serotonin in the frontal cortex but not in raphe nuclei. Synapse, 15:243–245.
Bell DS (1965) Comparison of amphetamine psychosis and schizophrenia.
British Journal of Psychiatry, 111:701–707.
Benkelfat C y colab. (1994) Mood-lowering effect of tryptophan depletion:
enhanced susceptibility in young men at genetic risk for major affective disorders.
Archives of General Psychiatry, 51:687–697.
Beyer CE, Steketee JD (2000) Intra-medial prefrontal cortex injection of quinpirole,
but not SKF 38393, blocks the acute motor-stimulant response to
cocaine in the rat. Psychopharmacology, 151:211–218.
Binder RL y colab. (1987) Smoking and tardive dyskinesia. Biological Psychiatry,
22:1280–1282.
Blaha CD y colab. (1997) Stimulation of the ventral subiculum of the hippocampus
evokes glutamate receptor-mediated changes in dopamine efflux in
the rat nucleus accumbens. European Journal of Neuroscience, 9:902–911.
Blier P, de Montigny C (1994) Current advances and trends in the treatment of
depression. Trends in Pharmacological Sciences, 15:220–226.
Blier P, de Montigny C, Chaput Y (1990) A role for the serotonin system in the
mechanism of action of antidepressant treatments: preclinical evidence. Journal
of Clinical Psychiatry, 51 Suppl: S14–S20.
Bogerts B (1993) Hippocampus-amygdala volumes and psychopathology in
chronic schizophrenia. Biological Psychiatry, 33:236–246.
Bokstrom K, Balldin J (1992) A rating scale for assessment of alcohol withdrawal
psychopathology (AWIP). Alcoholism: Clinical and Experimental Research,
16:241–249.
Breslau N (1995) Psychiatric comorbidity of smoking and nicotine dependence.
Behavior Genetics, 25:95–101.
Breslau N, Kilbey MM, Andreski P (1993) Nicotine dependence and major
depression: new evidence from a prospective investigation. Archives of General
Psychiatry, 50:31–35.
Breslau N y colab. (1998) Major depression and stages of smoking: a longitudinal
investigation. Archives of General Psychiatry, 55:161–166.
Buckley P y colab. (1994) Substance abuse among patients with treatment-resistant
schizophrenia: characteristics and implications for clozapine therapy.
American Journal of Psychiatry, 151:385–389.
Caldecott-Hazard S, Schneider LS (1992) Clinical and biochemical aspects of
depressive disorders. III. Treatment and controversies. Synapse, 10:141–168.
Caldecott-Hazard S y colab. (1991) Clinical and biochemical aspects of depressive
disorders. II. Transmitter/receptor theories. Synapse, 9:251–301.
Carlsson A (1977) Does dopamine play a role in schizophrenia? Psychological
Medicine, 7:583–597.
Carlsson A (1978) Mechanism of action of neuroleptic drugs. In: Lipton MA,
Di Mascio A, Killian KF, eds. Psychopharmacology: a generation in progress. Nueva
York, NY, EE.UU. Raven Press:1057–1070.
192